Newsletter | March 14, 2024

03.14.24 -- mRNA: Challenges & Opportunities For Scale-Out, Optimization

SPONSOR

Addressing The Challenge Of Scalability In Viral Vectors

Gene therapies have delivered remarkable outcomes for patients with a wide variety of diseases and conditions. As the opportunities to improve patient outcomes through these therapies rapidly expand, more efficient methods for upstream viral vector production are needed. Explore different methods for increasing vector productivity and ensuring robust scalability of upstream processes here.

FEATURED EDITORIAL

mRNA: Challenges And Opportunities For Scale-Out, Optimization

J. Andrew Case, head of supply chain – Cell & Gene Therapies at Genentech, and Daniel Getts, CEO and cofounder of Myeloid Therapeutics explore raw material issues and the importance of meeting efficient scale-out and turnaround times.

Audience Q&A | mRNA For Cancer Immunotherapy 2024 Outlook

During this Cell & Gene Live episode, expert panelists answered audience questions regarding patient safety, foreseeable challenges in mRNA cancer immunotherapy for solid tumors, and much more.

INDUSTRY INSIGHTS

Move Your Gene Therapy From Strategy To Reality

Implementing integrated solutions can provide cell and gene therapy manufacturing systems that work in concert to create a closed, automated, scalable, and performance-qualified network of unit operations.

Building A Compelling Business Case For Quality Transformation

Discover the key to a successful quality transformation, explore the business value of modern quality systems, and learn how quality leaders can build a compelling case for change.

Don’t Sign Yet: How To Detect And Avoid Hidden CRO Contract Costs

Navigating the complex landscape of clinical trials can be challenging. Utilize this reliable CRO Checklist to empower teams to stay ahead and safeguard every trial's budget effectively.

How Tunable Cell Processing Solutions Ensure Separation Efficiency

Single-use tubular bowl centrifuges are standing out to cell therapy developers for their ability enable the optimal balance between high separation efficiency, high productivity, and low shear.

Automation Of The CRISPR- Based Cell Line Development Workflow

Review an in-depth study of the automation of a mammalian cell-line development workflow — the automated, integrated screening of transfected cells for edits, monoclonality, and growth assessment.

Using Artificial Intelligence To Identify Clonally Derived Cell Lines

See how clonal imaging technology combined with a trained neural network can identify single cells reliably, demonstrating process accuracy and shortening development timelines.

Thinking Translational: Considerations In CAR T Cell Research Workflows

Learn how to set up a small-scale CAR T cell research workflow to simplify the transition to large-scale manufacturing in preclinical development, and why using suitable tools early on is key.

Evaluation Criteria Of Freezer Systems For Bulk Pharmaceuticals

Review data and evidence that demonstrates the benefits of an integrated approach to achieving critical end-user goals such as scalability, efficiency, sustainability, and optimized process economics.

Expansion Of DF-1 Cell Line In A Circulation/Perfusion System

This study establishes basic cell culture parameters for expansion of DF-1 cells in the Corning CellCube System — a compact and scalable method for mass culture of attachment-dependent cells.

Simplify The Qualification Of Your GMP Proteins With Maurice

Characterize the identity and purity of commonly used GMP cytokines in immune cell therapy manufacturing using an automated capillary electrophoresis instrument that's fast and easy to use.

Maximizing The Value Of Your AAV Using Small Volume AAV Testing

Consider this approach to method development, where more than one AAV critical quality attribute can be measured within a single analytical run, reducing the amount of test material required.

Powerful Batch Visualization Solution

Explore the offerings of a powerful batch solution that dramatically increases operator productivity and enables distributed batch control for a smarter approach to unit operations.

SPONSOR

Stem cells are the backbone of many allogeneic therapies and where they come from affects development and supply chain logistics, particularly cryopreservation. What temperatures are ideal to maintain product potency? How do you build a reliable cold chain? How do you work with existing infrastructure to allow for an “off-the-shelf” therapy? Don’t miss the next Cell & Gene Live digital event! Registration is free thanks to the support of Charter Medical and Bio-Techne.

SOLUTIONS

Introducing Slingshot Labs: The Controls Incubator

Plasmid DNA Manufacturing Service

Automated, Single-Use System For Clinical And Commercial LNP Production

CXP Cell Expansion Bio-Containers

Ensure Data Quality Through Mass Balance Calculations

Connect With Cell & Gene: